Join
Live feed
·
PRReleasevia Quantisnow
PRF Technologies Ltd. logo

PainReform Commences Development for OcuRing™-K Phase II Trial, LayerBio's Drop-Less Sustained-Release Ocular Therapy

ByQuantisnow·Wall Street's wire, on your screen.
PRFX· PRF Technologies Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PRFX (PRF Technologies Ltd.) and more on Quantisnow.